Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case - Eli Lilly (NYSE:LLY)

Supreme Court lets stand $194 million Medicaid fraud award against Eli Lilly in whistleblower case challenging False Claims Act.

Raccontata dabenzinga.com